How Much Did NeuroFlow Raise? Funding & Key Investors

NeuroFlow has successfully raised significant funding through multiple rounds, with the latest being a Venture - Series Unknown round on September 6, 2023. The company is backed by 19 investors, including Concord Health Partners and SEMCAP.

The platform offers a comprehensive suite of behavioral health solutions, including real-time data analytics, population engagement, and care team enablement. Keep reading to explore the intricacies of NeuroFlow's fundraising journey and the investors backing this innovative platform.

What Is NeuroFlow?

NeuroFlow, founded on April 26, 2017, is a digital health company based in Philadelphia, Pennsylvania. The company operates in the fitness, healthcare, mental health, mHealth, and wellness industries.

Founded by Adam Pardes and Christopher Molaro, NeuroFlow employs between 101-250 people. The platform is designed to optimize the delivery, tracking, and assessment of behavioral healthcare, supporting remote monitoring and behavioral health integration across various care settings.

How Much Funding Has NeuroFlow Raised?

1. Seed Round
   • Amount Raised: $1.3M
   • Date: October 2017
   • Lead Investors: Digital Health Fund
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To develop and launch the initial version of the platform.
2. Seed Round
   • Amount Raised: $2.3M
   • Date: September 2018
   • Lead Investors: Not publicly disclosed
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To expand the platform's capabilities and user base.
3. Series A
   • Amount Raised: $7.5M
   • Date: December 2019
   • Lead Investors: Builders VC
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To support the initial scaling of the platform and expand its user base and partnerships.
4. Series B
   • Amount Raised: $20M
   • Date: January 2021
   • Lead Investors: Magellan Health Services
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To scale operations, enhance data analytics, AI capabilities, and integrate with direct health records.
5. Grant
   • Amount Raised: $749.4K
   • Date: April 2020
   • Lead Investors: National Science Foundation
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To support research and development efforts.
6. Grant
   • Amount Raised: $750K
   • Date: September 2022
   • Lead Investors: Mission Daybreak
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To further develop and enhance the platform's capabilities.
7. Series C
   • Amount Raised: $25M
   • Date: October 2022
   • Lead Investors: SEMCAP
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To expand the platform's reach and enhance its technological capabilities.
8. Venture Round
   • Amount Raised: Not publicly disclosed
   • Date: September 2023
   • Lead Investors: Concord Health Partners
   • Valuation at Round: Not publicly disclosed
   • Motivation Behind the Round: To support ongoing growth and development initiatives.

Total Amount Raised: $57.6M

Current Valuation: Not publicly disclosed

Key Investors

• Concord Health Partners
  • Details: Concord Health Partners is a healthcare-focused investment firm. They aim to improve healthcare quality and reduce costs through strategic investments.
  • Investment Focus Areas: Healthcare services, medical technology, digital health.
  • Notable Investments: Not publicly disclosed.
• SEMCAP
  • Details: SEMCAP is a growth equity firm that invests in companies with transformative potential. They focus on sectors that are poised for significant growth.
  • Investment Focus Areas: Healthcare, education, technology.
  • Notable Investments: Not publicly disclosed.
• Mission Daybreak
  • Details: Mission Daybreak is an initiative aimed at preventing veteran suicide. They provide funding and support to innovative solutions addressing mental health challenges.
  • Investment Focus Areas: Mental health, veteran support, suicide prevention.
  • Notable Investments: Not publicly disclosed.
• Magellan Health Services
  • Details: Magellan Health Services is a healthcare company specializing in managing complex healthcare needs. They offer services in behavioral health, specialty health, and pharmacy benefits.
  • Investment Focus Areas: Behavioral health, specialty health, pharmacy benefits management.
  • Notable Investments: Not publicly disclosed.
• Builders VC
  • Details: Builders VC is a venture capital firm that invests in early-stage companies. They focus on industries that are undergoing significant transformation.
  • Investment Focus Areas: Healthcare, agriculture, industrial technology.
  • Notable Investments: Not publicly disclosed.

What's Next for NeuroFlow?

NeuroFlow stands at the cusp of significant growth opportunities, driven by the increasing demand for telehealth solutions and the integration of behavioral health into overall care. The company is poised to expand its network of care providers, leveraging AI and data analytics to enhance patient outcomes. With a user base that has grown tenfold to over 330,000 users, the potential for further expansion is substantial.

Future fundraising opportunities appear promising, as the successful Series B round indicates strong investor interest. The strategic partnership with Magellan Health, which includes access to a network of over 118,000 providers, further bolsters NeuroFlow's growth prospects. However, challenges such as ensuring data privacy, integrating new technologies, and maintaining the quality of care while scaling operations remain critical considerations.

Use Clay to Get Funding Data

Sales professionals, take your strategy to the next level by leveraging Clay’s platform to access comprehensive fundraising data on companies like NeuroFlow and gather other critical business insights.

Sign up for free to start making data-driven decisions and stay ahead of the competition.